Lautier D, Canitrot Y, Salmon J M
Laboratoire de Chimie Physique, Université de Perpignan, France.
Anticancer Res. 1994 Nov-Dec;14(6B):2589-95.
Multidrug-resistant (MDR) cells have been characterized by reduced accumulation of rhodamine 123 (R123). We addressed the question of whether R123 could compete with substrates or inhibitors (vinblastine, colchicine, verapamil) of P-glycoprotein (Pgp) overexpressed in MDR cells, using fluorescence image cytometry. Verapamil caused a dose-dependent increase in R123 accumulation. R123 accumulation was increased by vinblastine only at high levels and colchicine had no effect on R123 accumulation. Treatments with two drugs altered R123 accumulation depending on drug concentration ratio. The results indicate that vinblastine, R123 and verapamil can compete for outward transport by Pgp. A dual effect of vinblastine suggests that vinblastine can activate Pgp at low concentrations and inhibit R123 transport at higher concentrations.
多药耐药(MDR)细胞的特征是罗丹明123(R123)积累减少。我们使用荧光图像细胞术研究了R123是否能与MDR细胞中过表达的P-糖蛋白(Pgp)的底物或抑制剂(长春碱、秋水仙碱、维拉帕米)竞争的问题。维拉帕米导致R123积累呈剂量依赖性增加。长春碱仅在高浓度时增加R123积累,而秋水仙碱对R123积累没有影响。两种药物联合处理根据药物浓度比改变R123积累。结果表明,长春碱、R123和维拉帕米可以竞争Pgp的外向转运。长春碱的双重作用表明,长春碱在低浓度时可激活Pgp,而在高浓度时抑制R123转运。